%0 Journal Article
%T Rofecoxib prevents ctdsDNA against damage
%A Marwan S. M. Al-Nimer
%A Suad M. Al-Deen
%A Zainab W. Abdul Lateef
%J Journal of Basic and Clinical Pharmacy
%D 2011
%I 
%X Rofecoxib is a selective cyclooxygenase COX-2 enzyme inhibitor withchemoprotective effect against cancer in experimental models. This study aimed to investigate the effect of rofecoxib against ctds DNA damage induced by copper ions or ultraviolet (UV)B radiation. Aliquot ctdsDNA samples were incubated with copper sulfate solution (50 nmol) and rofecoxib (0.8 mol) was added either before or afterthe admixing the ctdsDNA with copper sulfate. In another experimental series, aliquot of ctdsDNA were exposed to UVB radiation for 30 min in absence or presence of rofecoxib. Rofecoxib significantly attenuated the separation of double strands of DNA (detected by increase the absorbance of DNA at 260 nm) induced by Cu ions.Rofecoxib significantly offered protection against UVB-induced DNA damage. It is concluded that rofecoxib offered protection against copper ions or UVB induced-DNA damage via different mechanisms not related to the inhibition COX-2.
%K Rofecoxib
%K ctdsDNA
%K UVB
%U http://www.jbclinpharm.com/Volume2Issue1Articles/PDF/JBCP_V2_I1_34.pdf